SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
18-Jun-24 7:38 PM View: | Parker Craig C Chief Executive Officer Director | Surrozen, Inc./de (SRZN) | 14-Jun-24 | Grant | 400 | $5.67 | $2,268.00 | 7% 5.42K to 5.82K | |
18-Jun-24 7:41 PM View: | Williams Charles O CFO and COO | Surrozen, Inc./de (SRZN) | 14-Jun-24 | Grant | 400 | $5.67 | $2,268.00 | 7% 5.46K to 5.86K | |
18-Jun-24 7:44 PM View: | Li Yang Exec. Vice President, Research | Surrozen, Inc./de (SRZN) | 14-Jun-24 | Grant | 400 | $5.67 | $2,268.00 | 4% 10.49K to 10.89K | |
08-Apr-24 4:24 PM View: | Kutzkey Tim Director 10% Owner | Surrozen, Inc./de (SRZN) | 04-Apr-24 | Purchase Duplicate | 193,548 | $15.50 | $2,999,990.00 | 45% 434.1K to 627.65K | |
08-Apr-24 5:27 PM View: | Parker Craig C Chief Executive Officer Director | Surrozen, Inc./de (SRZN) | 04-Apr-24 | Purchase | 1,474 | -- | -- | 100% 0 to 1.47K | |
08-Apr-24 4:23 PM View: | Column Group III Gp, Lp 10% Owner | Surrozen, Inc./de (SRZN) | 04-Apr-24 | Purchase | 193,548 | $15.50 | $2,999,990.00 | 45% 434.1K to 627.65K | |
08-Apr-24 5:30 PM View: | Williams Charles O CFO and COO | Surrozen, Inc./de (SRZN) | 04-Apr-24 | Purchase | 1,474 | -- | -- | 100% 0 to 1.47K | |
18-Dec-23 9:26 PM View: | Li Yang Exec. Vice President, Research | Surrozen, Inc./de (SRZN) | 15-Dec-23 | Grant | 2,085 | $5.67 | $11,822.00 | 100% 0 to 2.08K | |
18-Dec-23 9:27 PM View: | Williams Charles O Chief Financial Officer | Surrozen, Inc./de (SRZN) | 15-Dec-23 | Grant | 2,085 | $5.67 | $11,822.00 | 100% 0 to 2.08K | |
18-Dec-23 9:23 PM View: | Parker Craig C Chief Executive Officer Director | Surrozen, Inc./de (SRZN) | 15-Dec-23 | Grant | 2,046 | $5.67 | $11,600.80 | 100% 0 to 2.05K | |
20-Jun-23 6:03 AM View: | Parker Craig C Chief Executive Officer Director | Surrozen, Inc./de (SRZN) | 15-Jun-23 | Grant | 25,000 | $0.38 | $9,500.00 | 261% 9.58K to 34.58K | |
20-Jun-23 6:01 AM View: | Williams Charles O Chief Financial Officer | Surrozen, Inc./de (SRZN) | 15-Jun-23 | Grant | 25,000 | $0.38 | $9,500.00 | 261% 9.58K to 34.58K | |
20-Jun-23 6:02 AM View: | Yeh Wen-Chen Chief Scientific Officer | Surrozen, Inc./de (SRZN) | 15-Jun-23 | Grant | 17,638 | $0.38 | $6,702.44 | 184% 9.58K to 27.22K | |
19-Dec-22 6:52 PM View: | Williams Charles O Chief Financial Officer | Surrozen, Inc./de (SRZN) | 15-Dec-22 | Grant | 9,578 | $0.41 | $3,926.98 | 100% 0 to 9.58K | |
19-Dec-22 7:09 PM View: | Yeh Wen-Chen Chief Scientific Officer | Surrozen, Inc./de (SRZN) | 15-Dec-22 | Grant | 9,578 | $0.41 | $3,926.98 | 4% 219.56K to 229.14K | |
19-Dec-22 6:53 PM View: | Vanhove Geertrui Chief Medical Officer | Surrozen, Inc./de (SRZN) | 15-Dec-22 | Grant | 9,578 | $0.41 | $3,926.98 | 42% 22.83K to 32.41K | |
19-Dec-22 7:08 PM View: | Parker Craig C Chief Executive Officer Director | Surrozen, Inc./de (SRZN) | 15-Dec-22 | Grant | 9,578 | $0.41 | $3,926.98 | 100% 0 to 9.58K | |
15-Dec-22 9:30 AM View: | Blutt Mitchell J Md 10% Owner | Surrozen, Inc./de (SRZN) | 14-Dec-22 | Sale | 5,382,500 | -- | -- | (100%) 5.38M to 0 | |
13-Aug-21 7:26 PM View: | Blutt Mitchell J Md 10% Owner | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 3,497,500 | -- | -- | 121% 2.88M to 6.38M | |
13-Aug-21 7:36 PM View: | Livingston Kevin Harold | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant Duplicate | 1,885,000 | -- | -- | 71% 2.64M to 4.53M | |
13-Aug-21 7:41 PM View: | Jarrett Jennifer | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
13-Aug-21 7:36 PM View: | Livingston Kevin Harold | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition Duplicate | 1,885,000 | -- | -- | (42%) 4.53M to 2.64M | |
13-Aug-21 7:36 PM View: | Livingston Kevin Harold | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition (other) Duplicate | 759,000 | -- | -- | (29%) 2.64M to 1.89M | |
13-Aug-21 7:38 PM View: | Soffer Benny | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 1,885,000 | -- | -- | 71% 2.64M to 4.53M | |
13-Aug-21 7:38 PM View: | Haqq Christopher | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
13-Aug-21 7:26 PM View: | Blutt Mitchell J Md 10% Owner | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition | 1,000,000 | -- | -- | (16%) 6.38M to 5.38M | |
13-Aug-21 7:42 PM View: | Consonance Life Sciences | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition Duplicate | 1,885,000 | -- | -- | (42%) 4.53M to 2.64M | |
13-Aug-21 7:42 PM View: | Consonance Life Sciences | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition (other) Duplicate | 759,000 | -- | -- | (29%) 2.64M to 1.89M | |
13-Aug-21 7:39 PM View: | Santel Donald J | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
13-Aug-21 7:42 PM View: | Consonance Life Sciences | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant Duplicate | 1,885,000 | -- | -- | 71% 2.64M to 4.53M | |
13-Aug-21 7:38 PM View: | Soffer Benny | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition | 1,885,000 | -- | -- | (42%) 4.53M to 2.64M | |
13-Aug-21 7:38 PM View: | Soffer Benny | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Disposition (other) | 759,000 | -- | -- | (29%) 2.64M to 1.89M | |
03-Dec-20 6:07 AM View: | Soffer Benny Director | Surrozen, Inc./de (SRZN) | 01-Dec-20 | Purchase Duplicate | 24,000 | -- | -- | 6% 410.0K to 434.0K | |
03-Dec-20 6:07 AM View: | Consonance Life Sciences Director 10% Owner | Surrozen, Inc./de (SRZN) | 01-Dec-20 | Purchase | 24,000 | -- | -- | 6% 410.0K to 434.0K | |
03-Dec-20 6:06 AM View: | Livingston Kevin Harold Chief Financial Officer | Surrozen, Inc./de (SRZN) | 01-Dec-20 | Purchase Duplicate | 24,000 | -- | -- | 6% 410.0K to 434.0K | |
03-Dec-20 6:07 AM View: | Blutt Mitchell J Md Director | Surrozen, Inc./de (SRZN) | 01-Dec-20 | Purchase Duplicate | 24,000 | -- | -- | 6% 410.0K to 434.0K | |
25-Nov-20 4:05 PM View: | Soffer Benny Director | Surrozen, Inc./de (SRZN) | 23-Nov-20 | Purchase Duplicate | 410,000 | -- | -- | 100% 0 to 410.0K | |
25-Nov-20 4:05 PM View: | Blutt Mitchell J Md Director 10% Owner | Surrozen, Inc./de (SRZN) | 23-Nov-20 | Purchase Duplicate | 410,000 | -- | -- | 100% 0 to 410.0K | |
25-Nov-20 4:05 PM View: | Livingston Kevin Harold Chief Financial Officer | Surrozen, Inc./de (SRZN) | 23-Nov-20 | Purchase Duplicate | 410,000 | -- | -- | 100% 0 to 410.0K | |
04-Dec-20 9:28 PM View: | Blutt Mitchell J Md Director 10% Owner | Surrozen, Inc./de (SRZN) | 23-Nov-20 | Purchase | 1,000,000 | -- | -- | 230% 434.0K to 1.43M | |
25-Nov-20 4:05 PM View: | Consonance Life Sciences 10% Owner | Surrozen, Inc./de (SRZN) | 23-Nov-20 | Purchase | 410,000 | -- | -- | 100% 0 to 410.0K |